The Public Health Law Watch initiative identifies potential legislative and regulatory changes that have an impact to harm public health but have yet to break into the mainstream conversation, identifies ways to engage on these issues, and provides legal analysis and commentary.

Join us this week at NUSL's Annual Health Law Conference!

Join us this week at NUSL's Annual Health Law Conference!

We’ve really been looking forward to this timely and relevant conference at Northeastern’s Center for Health Policy and Law. We hope to see you there!

From the NUSL website:

PROMISES AND PERILS OF EMERGING HEALTH INNOVATIONS

Thursday, April 11 and Friday, April 12, 2019
Northeastern University 

Health care is rapidly changing. Over the last decade, striking innovations, including artificial intelligence, robotics, mobile technology, gene therapies, pharmaceuticals, big data analytics, tele- and virtual health care delivery, have been developed as new entities and modes of delivery, from accountable care organizations (ACOs) to retail minute-clinics, have entered the market. More dramatic innovations and market disruptions are likely in the years to come. These new technologies and market disruptions offer immense promise to advance health care quality and efficiency, as well as improve provider and patient engagement. Success will depend, however, on careful consideration of potential perils and well-planned interventions to ensure new methods ultimately further, rather than diminish, the health of patients, especially those who are the most vulnerable.

>> Download the flyer

Throughout the two-day conference, interdisciplinary experts, policymakers, academics, and providers will attempt to answer myriad questions, including:

What are the legal, policy, and ethical considerations regarding new health technologies? New forms of organization?
What safety and privacy issues will arise from new health technologies? How will this change over time?
What protections can we put 
into place to protect privacy as the market changes and technologies evolve?
Who is ultimately accountable for the development, use, and oversight of emerging health technologies and innovations?
What legal mechanisms exist for promoting access to and serving underserved populations?
Should new innovations focus on clinical health care, population health, public health, or some combination?
Whom do these new technologies and entities ultimately serve (providers, patients, private companies) and how does that lens impact how we incorporate them into the health care system?

The conference is free and open to the public

EDGI: EPA didn't provide enough information for true public comment on WOTUS rule

EDGI: EPA didn't provide enough information for true public comment on WOTUS rule

Trump returns Obamacare to the crosshairs and we are all in peril

Trump returns Obamacare to the crosshairs and we are all in peril